Screener
Lexicon Pharmaceuticals LXRX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's accounts payable?
- Lexicon Pharmaceuticals (LXRX) reported accounts payable of $2.34M in Q2 2026.
- How has Lexicon Pharmaceuticals's accounts payable changed year-over-year?
- Lexicon Pharmaceuticals's accounts payable decreased by 60.3% year-over-year, from $5.9M to $2.34M.
- What is the long-term trend for Lexicon Pharmaceuticals's accounts payable?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's accounts payable has grown at a -10.8% compound annual growth rate (CAGR), from $5.47M to $3.08M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Lexicon Pharmaceuticals's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude